FDA Inspection
Amgen Technology (Ireland) Unlimited CompanyAmgen Technology (Ireland) Unlimited Company – FDA Inspection, Sep 22, 2017
Record Details
This FDA Inspection record concerns Amgen Technology (Ireland) Unlimited Company, with an inspection on September 22, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 22, 2017
- Product Type
- Drugs
View Company Profile
ID · 9d92991b-b5b6-47cf-8450-cbb78defcedc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1026365
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Amgen Technology (Ireland) Unlimited Company
10| Date | Classification | Office | Project area |
|---|---|---|---|
| September 16, 2025 | Not classified | Office of Inspections and Investigations | |
| July 25, 2024 | NAI | Compliance: Devices | |
| September 13, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 16, 2023 | Not classified | Office of Inspections and Investigations | |
| July 28, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Amgen Technology (Ireland) Unlimited Company
- FDA Inspection 1278033 - 2025-09-16
- FDA Inspection 1241641 - 2024-07-25
- FDA Inspection 1221006 - 2023-09-13
- FDA Inspection 1251108 - 2023-08-16
- FDA Inspection 1228800 - 2023-07-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.